Skip to NavigationSkip to content

News

Research from the University of Kent and King’s College London has revealed that UK sales of prescription psychiatric drugs, including those such...
Senior Executives from seven major pharmaceutical companies, including AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi...
New data has been released on Sanofi’s Dupixen, derived from two Phase 3 trials, illustrating the drug’s efficacy In combination with standard of...
A British scientist has developed innovative technology that is able to deliver drugs deep into the brain in order to treat neurological diseases...
With full coverage of Trump's health commitments in the SOTU address, a feature-length look at the latest amazing developments in cancer research,...
Amgen is celebrating after a Delaware jury backed the validity of two of its patents against challenges from Regeneron and Sanofi.
Vitamin D deficiency may weaken supportive ‘scaffolding’ in the brain thus causing neurons difficulty in maintaining connections, according to a...
AstraZeneca and MSD have lifted the curtain on new Phase 3 data for Lynparza (olaparib), confirming that the drug generated a “statistically-...
A French boy is suspected of reintroducing measles to Costa Rica after the country has been free of the infectious disease for five years.
Parent’s reluctance to vaccinate their children correlates with the number of people voting for populist parties, according to a study published in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches